In 2019 funding will be made available for 8 RIMLS Junior Researcher projects. The call for these PhD grants is now open.
The funding will be made available for junior researcher projects. These positions will be distributed over the three research institutes based on the number of (j)PIs in these institutes. The calls will be organized by the three research institutes separately.
The criteria for application and the application form can be found via this link.
Procedure:An external representative jury will be installed to review the projects and CV’s of the main applicants. The jury will rank projects according to:
- Novelty, innovation & impact
- Scientific quality
- Past performance of the main applicant
- Relevance to the Theme and RIMLS
- International nature of the project
- Final assessment
Submission of proposal : 27 May 2018 to firstname.lastname@example.org
Review to applicants : 22 June 2018 to applicant
Rebuttal : 1 July 2018 to email@example.com
Final decision to applicants: October 2018 to applicant
Want to know more about these subjects? Click on the buttons below for more news.
RIMLSNanomedicine Cancer development and immune defenseRare cancersTumors of the digestive tract Urological cancersWomen's cancersInfectious diseases and global healthInflammatory diseases Metabolic disordersReconstructive and regenerative medicineRenal disorders Vascular damage Calls RIMLS
Related news items
Nijmegen literally puts Digital Health on the map Flourishing ecosystem gets its own interactive overview22 July 2021
Digital Health is thriving in the Nijmegen region, where it contributes to better care and health and also creates jobs. To bring developers and end users even closer together, The Economic Board and the Radboudumc are introducing the Interactive Digital Health map.read more
Michiel Vermeulen and Klaas Mulder receive funding from ZonMw for a collaborative project using stem cell-based models15 July 2021
Michiel Vermeulen and Klaas Mulder, theme Cancer development and immune defense, receive funding from ZonMw for a collaborative project to develop a stem cell based model to study early human embryogenesis.read more
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development15 July 2021
The partnership will accelerate the development of new Tuberculosis (TB) drug regimens as part of the Innovative Medicines Initiative (IMI), a public-private European Research & Development Consortiumread more